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Purpose of the study
Framingham risk index overestimates the probability of
coronary heart disease (CHD) in populations with low
incidence.
Methods
We estimated the 10-year coronary risk in a sample of
Spanish outpatients in our HIV clinic, using the standard
Framingham index and an index developed and validated
in a population of Catalonia (Northern Spain): REGI-
COR. The following data were collected in all patients:
age, gender, smoking status, HIV risk group, CD4+ cell
count, HIV viral load, fasting glucose and insulin levels,
lipid profile, blood pressure, waist circumference, BMI
and present ART. We used the HOMA (homeostatic
model assessment) index to assess insulin resistance,
choosing as cut-off point, 3.8. The IDF (International Dia-
betes Foundation) criteria have been used to define
increased waist circumference, hypertension, hypertry-
gliceridemia, low HDL-cholesterol and hyperglycemia.
Summary of results
128 outpatients seen in our clinic between January 1 and
June 30, 2007, were included. Ninety-seven (72%) were
males, median age was 43 years and 37% had sexually
transmitted HIV infection. At the time of the study
median CD4+ cell count was 397 cells/μL, 78% had a viral
load below 50 copies/mL, and 118 were receiving HAART.
6.3% had diabetes and 28.9% arterial hypertension.
Median blood total cholesterol, HDL-cholesterol, LDL
and triglycerides were 172.5 mg/dL, 42 mg/dL, 92 mg/dL
and 134 mg/dL, respectively. Forty-one percent were over-
weight, 20% had insulin resistance as estimated by
HOMA and 51.6% fulfilled IDF criteria for abdominal
obesity; 74.2% were current smokers. Using the REGICOR
index, estimated 10-year CHD risk greater than 5% was
3.3 times lower than by Framingham index (14.2% vs.
46.9%). An estimated probability of CHD events over
15% in 10 years was five times lower using REGICOR
index than with the standard Framingham index (0.8% vs.
3.9%).
Conclusion
REGICOR index seems more accurate for the assessment
of CHD risk in primary prevention in Spain, and presum-
ably so in HIV-infected patients as well. It should be vali-
dated in other Spanish regions and specifically in HIV-
infected patients. This would have an impact on therapeu-
tic decisions.
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